Unraveling the mystery of white matter in depression: A translational perspective on recent advances.
Fractional anisotropy
MRI
Major depressive disorder
postmortem
primates
rodents
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
revised:
15
04
2022
received:
19
11
2021
accepted:
23
04
2022
pubmed:
3
6
2022
medline:
26
7
2022
entrez:
2
6
2022
Statut:
ppublish
Résumé
Numerous cortical and subcortical structures have been studied extensively concerning alterations of their integrity as well as their neurotransmitters in depression. However, connections between these structures have received considerably less attention. This systematic review presents results from recent neuroimaging as well as neuropathologic studies conducted on humans and other mammals. It aims to provide evidence for impaired white matter integrity in individuals expressing a depressive phenotype. A systematic database search in accordance with the PRISMA guidelines was conducted to identify imaging and postmortem studies conducted on humans with a diagnosis of major depressive disorder, as well as on rodents and primates subjected to an animal model of depression. Alterations are especially apparent in frontal gyri, as well as in structures establishing interhemispheric connectivity between frontal regions. Translational neuropathological findings point to alterations in oligodendrocyte density and morphology, as well as to alterations in the expression of genes related to myelin synthesis. An important role of early life adversities in the development of depressive symptoms and white matter alterations across species is thereby revealed. Data indicating that stress can interfere with physiological myelination patterns is presented. Altered myelination is most notably present in regions that are subject to maturation during the developmental stage of exposure to adversities. Translational studies point to replicable alterations in white matter integrity in subjects suffering from depression across multiple species. Impaired white matter integrity is apparent in imaging as well as neuropathological studies. Future studies should focus on determining to what extent influencing white matter integrity is able to improve symptoms of depression in animals as well as humans.
Sections du résumé
BACKGROUND
Numerous cortical and subcortical structures have been studied extensively concerning alterations of their integrity as well as their neurotransmitters in depression. However, connections between these structures have received considerably less attention.
OBJECTIVE
This systematic review presents results from recent neuroimaging as well as neuropathologic studies conducted on humans and other mammals. It aims to provide evidence for impaired white matter integrity in individuals expressing a depressive phenotype.
METHODS
A systematic database search in accordance with the PRISMA guidelines was conducted to identify imaging and postmortem studies conducted on humans with a diagnosis of major depressive disorder, as well as on rodents and primates subjected to an animal model of depression.
RESULTS
Alterations are especially apparent in frontal gyri, as well as in structures establishing interhemispheric connectivity between frontal regions. Translational neuropathological findings point to alterations in oligodendrocyte density and morphology, as well as to alterations in the expression of genes related to myelin synthesis. An important role of early life adversities in the development of depressive symptoms and white matter alterations across species is thereby revealed. Data indicating that stress can interfere with physiological myelination patterns is presented. Altered myelination is most notably present in regions that are subject to maturation during the developmental stage of exposure to adversities.
CONCLUSION
Translational studies point to replicable alterations in white matter integrity in subjects suffering from depression across multiple species. Impaired white matter integrity is apparent in imaging as well as neuropathological studies. Future studies should focus on determining to what extent influencing white matter integrity is able to improve symptoms of depression in animals as well as humans.
Identifiants
pubmed: 35652161
doi: 10.1002/brb3.2629
pmc: PMC9304855
doi:
Types de publication
Journal Article
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2629Informations de copyright
© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
PLoS One. 2014 Nov 13;9(11):e112307
pubmed: 25393297
Mol Neurobiol. 2013 Feb;47(1):131-44
pubmed: 23054677
PLoS One. 2012;7(9):e45476
pubmed: 23029036
Genes Brain Behav. 2019 Jan;18(1):e12475
pubmed: 29566304
Biol Psychiatry. 2008 Oct 15;64(8):730-733
pubmed: 18620337
Neurol Clin. 2003 Aug;21(3):575-607
pubmed: 13677814
Neuropsychopharmacology. 2011 Feb;36(3):684-91
pubmed: 21085111
J Comp Neurol. 2021 Jul 1;529(10):2750-2770
pubmed: 33543493
Brain Res Bull. 1998 Nov 1;47(4):297-310
pubmed: 9886780
J Affect Disord. 2010 Jan;120(1-3):240-4
pubmed: 19467559
J Affect Disord. 2013 Sep 5;150(2):330-6
pubmed: 23680435
Eur J Radiol. 2011 Nov;80(2):450-4
pubmed: 20634013
EMBO Mol Med. 2012 Jun;4(6):528-39
pubmed: 22473874
Rofo. 2000 Oct;172(10):802-11
pubmed: 11111291
J Neurosci. 2014 Jul 23;34(30):10041-54
pubmed: 25057206
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):395-409
pubmed: 21044654
Psychiatry Investig. 2019 Sep;16(9):662-670
pubmed: 31550875
J Neuropsychiatry Clin Neurosci. 2016 Spring;28(2):131-7
pubmed: 26548656
Front Psychiatry. 2018 Oct 02;9:450
pubmed: 30333763
Neuroimage. 2006 Sep;32(3):989-94
pubmed: 16854598
Behav Brain Res. 2021 Sep 24;414:113504
pubmed: 34331971
J Neurochem. 2014 Oct;131(2):229-38
pubmed: 24934403
Compr Psychiatry. 2000 Mar-Apr;41(2):97-102
pubmed: 10741886
Psychol Med. 2005 Sep;35(9):1275-82
pubmed: 16168150
Lancet Psychiatry. 2017 Feb;4(2):146-158
pubmed: 27856392
Eur Psychiatry. 2017 Jan;39:51-56
pubmed: 27821355
Neuropsychol Rev. 2010 Jun;20(2):209-25
pubmed: 20422451
J Neurosci. 2013 Jun 5;33(23):9752-9768
pubmed: 23739972
Diabetes Care. 1996 Oct;19(10):1097-102
pubmed: 8886555
Transl Psychiatry. 2012 May 01;2:e109
pubmed: 22832953
Biochim Biophys Acta. 2015 Aug;1851(8):1052-65
pubmed: 25542508
Brain. 1989 Jun;112 ( Pt 3):799-835
pubmed: 2731030
Sci Rep. 2020 Dec 31;10(1):22431
pubmed: 33384453
Sci Rep. 2017 Aug 29;7(1):9707
pubmed: 28852030
Transl Psychiatry. 2018 Aug 1;8(1):141
pubmed: 30069019
J Affect Disord. 2021 Mar 1;282:91-97
pubmed: 33401128
Int J Neuropsychopharmacol. 2017 May 1;20(5):363-373
pubmed: 28034960
Eur J Neurosci. 2021 Jun;53(12):3920-3941
pubmed: 32757397
Mol Cell Neurosci. 1996 Jun;7(6):453-66
pubmed: 8875429
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:277-84
pubmed: 26111720
Z Rheumatol. 2019 Apr;78(3):243-248
pubmed: 30488094
J Neuropsychiatry Clin Neurosci. 1994 Fall;6(4):371-8
pubmed: 7841808
Eur J Clin Invest. 2011 Nov;41(11):1245-53
pubmed: 21521185
Neurosci Biobehav Rev. 2018 Sep;92:104-127
pubmed: 29753752
Psychiatry Res. 2019 Nov;281:112544
pubmed: 31499341
J Comp Neurol. 2018 Feb 15;526(3):537-549
pubmed: 29098693
J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):469-75
pubmed: 15774430
Int J Neuropsychopharmacol. 2021 Jul 23;24(7):542-550
pubmed: 33667309
Neuroimage. 2007 Apr 1;35(2):478-87
pubmed: 17292629
Psychiatry Res Neuroimaging. 2017 Jun 30;264:29-34
pubmed: 28437669
Psychiatry Res. 2020 Jul;289:112979
pubmed: 32438208
Chem Biol. 2015 Apr 23;22(4):446-452
pubmed: 25865309
Neuroimage. 2011 Sep 1;58(1):41-9
pubmed: 21640837
Acta Psychiatr Scand. 2007 Sep;116(3):211-9
pubmed: 17655563
J Affect Disord. 2016 Mar 1;192:167-75
pubmed: 26735328
Bull N Y Acad Med. 1942 Dec;18(12):794-812
pubmed: 19312295
Dev Med Child Neurol. 2012 Jan;54(1):6-7
pubmed: 22098073
Neuroimage. 2016 Nov 15;142:544-552
pubmed: 27520750
East Asian Arch Psychiatry. 2011 Mar;21(1):5-9
pubmed: 21837850
Exp Brain Res. 2021 Oct;239(10):2999-3005
pubmed: 34331083
Sci Rep. 2016 Mar 15;6:23084
pubmed: 26976207
Neurosci Lett. 2010 Aug 16;480(2):93-6
pubmed: 20541590
J Am Acad Child Adolesc Psychiatry. 2020 Jul;59(7):842-855
pubmed: 31676392
Brain Res. 2011 Jan 19;1369:223-9
pubmed: 21047498
Lancet. 2018 Nov 10;392(10159):1789-1858
pubmed: 30496104
PLoS One. 2013;8(2):e57780
pubmed: 23451267
J Psychiatr Res. 2015 Jun;65:53-62
pubmed: 25930075
J Affect Disord. 2018 May;232:61-68
pubmed: 29477585
Front Syst Neurosci. 2021 Dec 14;15:733898
pubmed: 34970125
J Comp Neurol. 2017 Jun 1;525(8):1922-1933
pubmed: 28118485
Genes Dev. 2006 Mar 1;20(5):515-24
pubmed: 16510870
J Cell Biol. 2008 Jun 30;181(7):1169-77
pubmed: 18573915
Handb Clin Neurol. 2016;135:39-60
pubmed: 27432659
Schizophr Res. 2009 Mar;108(1-3):41-8
pubmed: 19103476
World J Biol Psychiatry. 2017 Dec;18(8):615-623
pubmed: 27388597
Metabolism. 2005 May;54(5 Suppl 1):49-52
pubmed: 15877314
Cereb Cortex. 2020 Sep 3;30(10):5218-5228
pubmed: 32324856
Magn Reson Imaging. 2008 Sep;26(7):874-88
pubmed: 18524521
Brain. 2002 Mar;125(Pt 3):551-61
pubmed: 11872612
J Nerv Ment Dis. 2013 Dec;201(12):1007-20
pubmed: 24284634
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):503-514
pubmed: 28802862
PLoS One. 2015 Jun 26;10(6):e0130833
pubmed: 26114630
Nat Neurosci. 2005 Apr;8(4):468-75
pubmed: 15793579
J Immunol. 1994 Nov 15;153(10):4349-56
pubmed: 7525700
Pharmacogenet Genomics. 2009 Oct;19(10):735-41
pubmed: 19741570
Expert Rev Neurother. 2012 Sep;12(9):1143-61
pubmed: 23039393
Neuroscience. 2008 Mar 27;152(3):573-84
pubmed: 18295409
Int J Bipolar Disord. 2021 Mar 8;9(1):9
pubmed: 33683478
J Magn Reson Imaging. 2014 Apr;39(4):917-23
pubmed: 24123288
Front Neuroanat. 2016 Sep 07;10:84
pubmed: 27656132
Neuropsychopharmacology. 2011 Dec;36(13):2650-8
pubmed: 21814185
J Magn Reson Imaging. 2005 Jun;21(6):735-43
pubmed: 15906348
J Neurosci. 2007 Oct 24;27(43):11552-9
pubmed: 17959798
J Comp Neurol. 2016 Dec 1;524(17):3577-3586
pubmed: 27075416
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110306
pubmed: 33745977
Neuroscience. 2014 Sep 5;275:12-21
pubmed: 24881571
Mol Psychiatry. 2018 Oct;23(10):2018-2028
pubmed: 29158585
AJNR Am J Neuroradiol. 2007 Jun-Jul;28(6):1102-6
pubmed: 17569968
Transl Psychiatry. 2016 Aug 09;6(8):e866
pubmed: 27505229
Annu Rev Cell Dev Biol. 2007;23:175-205
pubmed: 17506695
J Affect Disord. 2018 Jan 15;226:339-345
pubmed: 29031184
Brain Behav. 2022 Jul;12(7):e2629
pubmed: 35652161
J Neurosci. 2007 Apr 18;27(16):4233-42
pubmed: 17442807
Am J Psychiatry. 2004 Nov;161(11):1957-66
pubmed: 15514393
Pharmacol Biochem Behav. 2011 Nov;100(1):59-65
pubmed: 21835191
Biomed Res Int. 2015;2015:542467
pubmed: 26413531
Psychiatry Res. 2011 Jan 30;191(1):80-3
pubmed: 21145709
Neuroscience. 2009 Mar 17;159(2):915-25
pubmed: 19000745
Neurobiol Aging. 2012 Jan;33(1):9-20
pubmed: 20122755
Psychiatry Res. 1999 Dec 20;92(2-3):75-81
pubmed: 10674361
Brain Imaging Behav. 2021 Aug;15(4):2159-2167
pubmed: 33155171
PLoS One. 2012;7(8):e44248
pubmed: 22957005
Am J Psychiatry. 2017 Dec 1;174(12):1185-1194
pubmed: 28750583
Neurosci Lett. 2012 Aug 1;522(2):139-44
pubmed: 22721700
Nat Neurosci. 2005 Jun;8(6):745-51
pubmed: 15895088
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
pubmed: 12489094
Neurosci Lett. 2019 Feb 16;694:104-110
pubmed: 30423401